Published in Oncotarget on November 05, 2016
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol (2014) 0.98
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci (2016) 0.94
miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R. Int J Gynecol Cancer (2016) 0.85
Association between HMGB1 and COPD: A Systematic Review. Mediators Inflamm (2015) 0.84
MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol (2016) 0.84
miR-196, an Emerging Cancer Biomarker for Digestive Tract Cancers. J Cancer (2016) 0.82
Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals. Am J Cancer Res (2015) 0.82
High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis. Int J Biol Markers (2015) 0.81
The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. J Clin Med (2016) 0.80
MicroRNA target finding by comparative genomics. Methods Mol Biol (2014) 0.80
The prognostic value of p53 expression for patients with cervical cancer: a meta analysis. Eur J Obstet Gynecol Reprod Biol (2015) 0.80
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. Cancer Med (2016) 0.80
PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation. Nucleic Acids Res (2016) 0.80
The implication of microRNAs and endo-siRNAs in animal germline and early development. Dev Biol (2016) 0.79
Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome. Brachytherapy (2015) 0.79
MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma. Cell Physiol Biochem (2015) 0.79
MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer. Asian Pac J Cancer Prev (2015) 0.78
Age-related incidence of cervical cancer supports two aetiological components: a population-based register study. BJOG (2015) 0.78
Polymorphisms in immune mediators associate with risk of cervical cancer. Gynecol Oncol (2014) 0.78
A team care model of cervical screening in a general practice. Aust Fam Physician (2015) 0.78
Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis. Biochemistry (Mosc) (2016) 0.77
The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy. Ann Transl Med (2015) 0.77
Working toward consensus among professionals in the identification of classical cervical cytomorphological characteristics in whole slide images. J Pathol Inform (2015) 0.77